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N-linked protein glycosylation follows a conserved pathway
in eukaryotic cells. The assembly of the lipid-linked core
oligosaccharide Glc3Man9GlcNAc2, the substrate for the
oligosaccharyltransferase (OST), is catalyzed by different
glycosyltransferases located at the membrane of the endo-
plasmic reticulum (ER). The substrate specificity of the dif-
ferent glycosyltransferase guarantees the ordered assembly of
the branched oligosaccharide and ensures that only completely
assembled oligosaccharide is transferred to protein. The gly-
cosyltransferases involved in this pathway are highly specific,
catalyzing the addition of one single hexose unit to the lipid-
linked oligosaccharide (LLO). Here, we show that the doli-
chylphosphomannose-dependent ALG9 mannosyltransferase
is the exception from this rule and is required for the addition
of two different -1,2-linked mannose residues to the LLO.
This report completes the list of lumen-oriented glycosyltrans-
ferases required for the assembly of the LLO.
Key words: endoplasmic reticulum/dolichol/Saccharomyces 
cerevisiae
Introduction
N-linked glycosylation in eukaryotic cells is an essential
post-translational modification of proteins in the secretory
pathway (Kornfeld and Kornfeld, 1985). A key feature is
the transfer of the pre-assembled branched oligosaccharide
Glc3Man9GlcNAc2. The assembly of Glc3Man9GlcNAc2
on the lipid-carrier dolichylpyrophosphate (PP-Dol) at the
membrane of the endoplasmic reticulum (ER) and the ini-
tial trimming reactions of the oligosaccharide after transfer
to protein are highly conserved processes in eukaryotes
(Herscovics and Orlean, 1993; Burda and Aebi, 1999). The
N-linked oligosaccharide fulfills different functions in the
maturation of the glycoprotein, such as glycoprotein qual-
ity control or lectin-mediated sorting in the secretory path-
way (Helenius, 2001; Trombetta, 2003; Helenius and Aebi,
2004). Therefore, it is of central importance that only the
complete Glc3Man9GlcNAc2 oligosaccharide is transferred
to protein, not biosynthetic intermediates or incorrectly
assembled structures. This is accomplished primarily by the
substrate specificity of the oligosaccharyltransferase (OST)
that transfers the oligosaccharide to protein and the indi-
vidual glycosyltransferases involved in the substrate assem-
bly (Murphy and Spiro, 1981; Burda et al., 1999; Cipollo
and Trimble, 2000; Karaoglu et al., 2001).
Lipid-linked oligosaccharide (LLO) biosynthesis starts
on the cytoplasmic side of the ER membrane by transfer of
GlcNAc-P to dolichylphosphate (P-Dol), followed by the
addition of GlcNAc and five mannose residue-yielding
Man5GlcNAc2-PP-Dol (Figure 1). Nucleotide-activated
sugars serve as substrates for these reactions. After Rft1p-
dependent translocation of the heptasaccharide moiety into
the lumen of the ER (Helenius and Aebi, 2002), four more
mannoses are added from the lipid-linked donor Man-P-Dol,
and the 14mer oligosaccharide is completed by transfer of
three glucoses from Glc-P-Dol. Finally, the multi-subunit
complex OST recognizes the full-length substrate and trans-
fers it to asparagine residues in the context Asn-X amino
acid-Ser/Thr, where X amino acid can be any amino acid except
proline (Gavel and Von Heijne, 1990; Knauer and Lehle, 1999;
Yan and Lennarz, 1999; Dempski and Imperiali, 2002).
Yeast alg (asparagine-linked glycosylation) (Huffaker
and Robbins, 1982) mutants have been pivotal for elucida-
tion of the pathway components, as all 10 known genes
encoding glycosyltransferases involved in LLO biosynthesis
were initially cloned by complementation of corresponding
mutations (Burda et al., 1999). alg mutant strains are char-
acterized by accumulation of the LLO substrate of the
affected glycosyltransferases, suggesting the absence of
redundant transferases. However, because of the branched
structure of the oligosaccharide, LLO biosynthesis can pro-
ceed in some mutant strains, resulting in aberrant oligosac-
charide structures that are then transferred to protein
(Cipollo et al., 2001; Helenius and Aebi, 2002).
The high degree of conservation of this pathway in
eukaryotes has enabled rapid elucidation of the molecular
basis of several human diseases caused by deficiencies in the
ER glycosylation pathway, known as congenital disorders
of glycosylation (CDG) (Aebi and Hennet, 2001; Marquardt
and Denecke, 2003). As mentioned above, the understand-
ing of the LLO biosynthetic pathway is not complete. In
particular, the mannosyltransferase responsible for the addi-
tion of the terminal α-1,2-linked mannose of the C-antenna
(residue k in Figure 1B) has not been identified (Burda
et al., 1999). On the basis of the current models (Figure 1),
it is proposed that Man-P-Dol serves as a donor in this
reaction. The known Man-P-Dol-dependent mannosyltrans-
ferases of the pathway, Alg3p, Alg9p, and Alg12p, are
hydrophobic proteins with multiple predicted transmembrane
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domains. They belong to a group of related transferases
which includes also enzymes involved in GPI-anchor for-
mation (Oriol et al., 2002). Members of this family without
assigned function would be prime candidates for the miss-
ing transferase. Yet in Saccharomyces cerevisiae, all family
members have already a suggested function. Interestingly,
no yeast mutant strain accumulating Man8GlcNAc2-PP-
Dol (residues a–j in Figure 1) has been isolated so far,
despite several genetic screens that have been conducted to
identify mutants in this pathway (Huffaker and Robbins,
1982; Roos et al., 1994; Burda et al., 1996, 1999; Burda and
Aebi, 1998).
The failure to isolate a Man8GlcNAc2-PP-Dol-accumu-
lating mutant could be explained by a model in which a
mannosyltransferase acting earlier in the pathway also cat-
alyzes addition of the mannose in question.
On the basis of the assumption that there is a high link-
age specificity of the glycosyltransferases involved, the
Man-P-Dol-dependent mannosyltransferases Alg3p and
Alg12p can be ruled out as possible dual-function candi-
dates, as these transferases add an α-1,3- or α-1,6-linked
mannose, respectively. In contrast, the ALG9 mannosyl-
transferase has previously been shown to be required for
the addition of the α-1,2-linked seventh mannose which ter-
minates the B-arm (residue i in Figure 1) (Burda et al.,
1996; Cipollo and Trimble, 2000). Cells lacking Alg9p
accumulate Man6GlcNAc2-PP-Dol, but an abnormal
Man7GlcNAc2 LLO with the acceptor residue (j in Figure 1)
for mannose k can be obtained by overexpression of
ALG12 in a ∆alg9 strain (Burda et al., 1999). Interestingly,
this Man7GlcNAc2 LLO lacks both terminal α-1,2-linked
mannose residues despite the absence of one single trans-
ferase, Alg9p. This implies that either the responsible man-
nosyltransferase has a strict requirement for presence of the
terminal α-1,2 mannose on the B-arm or that this transferase
is Alg9p.
We have investigated the hypothesis that mannose k is
added by Alg9p. Using an in vitro assay for elongation of
LLO and by analysis of the effects of Alg9p overexpression,
we provided evidence that Alg9p is involved in addition of
both the seventh and the ninth mannose to the LLO of
N-glycan biosynthesis. It is thus the first example of a
transferase in this conserved pathway found to add two
saccharides.
Results
First, we followed a biochemical approach to test whether
Alg9p is required for addition of the ninth mannose to
Man8GlcNAc2-PP-Dol. This employed an in vitro assay for
elongation of Man7GlcNAc2-PP-Dol to Man9GlcNAc2-
PP-Dol. We used [3H]mannose-labeled Man7GlcNAc2-PP-
Dol (residues a–i) isolated from a strain lacking Alg12p
(Burda et al., 1999) as the acceptor LLO substrate. Crude
membrane extracts isolated from wildtype ∆alg9 or ∆alg12
strains were mixed with LLO substrate in the presence of
detergent. Addition of GDP mannose was required to allow
formation of Man-P-Dol by dolichol-phosphate-mannose
synthase in vitro, while UDP-Glc was left out to avoid
formation of glucosylated LLOs. Alterations of the radio-
active oligosaccharide were then analyzed by HPLC.
Wildtype membranes elongated the input substrate
(Figure 2B) by one or two hexose units to species co-migrating
with Man8GlcNAc2 and Man9GlcNAc2, respectively
(Figure 2C). In contrast, membranes from ∆alg9 cells elon-
gated Man7GlcNAc2-PP-Dol only by one hexose unit
(Figure 2D). No elongation of Man7GlcNAc2-PP-Dol was
observed with ∆alg12 membranes (Figure 2E). This demon-
strates that the first elongation was Alg12p dependent and
that the second elongation from Man8GlcNAc2-PP-Dol to
Man9GlcNAc2-PP-Dol depended on Alg9p. Like in vivo,
Fig. 1. Scheme of lipid-linked oligosaccharide (LLO) biosynthesis at the lumenal side of the endoplasmic reticulum (ER) membrane. Four mannoses and 
three glucoses are added in a stepwise manner from Man-P-Dol and Glc-P-Dol, respectively. Genes involved in the respective glycosyl-transfer step are 
indicated atop the arrow. Darker circles indicate mannoses added from GDP-Man on the cytoplasmic side, lighter circles indicate mannoses added on the 
lumenal side from Man-P-Dol. Inset: linkage map of the Man9GlcNAc2 oligosaccharide. Monosaccharides are labeled with letters in alphabetic order of 
addition. The A-, B-, and C-arm are indicated by italic letters. Abbreviations used are α2 (α-1,2), α3 (α-1,3), α6 (α-1,6), and β4 (β-1,4).
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also in the in vitro assay addition of the α-1,6-linked man-
nose on the C-arm (residue j) by Alg12p preceded addition
of the terminal α-1,2-linked mannose.
To exclude that deletion of ALG9 results in an inhibiting
activity which would mask the α-1,2 mannosyltransferase
activity, we mixed membranes from wildtype and ∆alg9
cells and looked for substrate elongation. A peak at position
of Man9GlcNAc2 could still be observed (data not shown),
which rules out the presence of an inhibiting activity.
To verify that the oligosaccharides generated in the assay
had the presumed Man8GlcNAc2 or Man9GlcNAc2 struc-
tures, we collected individual oligosaccharide species,
digested them with an α-1,2 specific exo-mannosidase and
analyzed them by HPLC(Figure 3). The material from
elongation assays with wildtype membranes showed the
expected behavior (Figure 3B–D): Man7GlcNAc2 shifted upon
treatment to a Man4GlcNAc2 isomer, while Man8GlcNAc2
and Man9GlcNAc2 both shifted to the same Man5GlcNAc2
isomer, demonstrating that they only differed by a terminal
α-1,2-linked mannose.
Digestion of the Man8GlcNAc2 peak generated with
∆alg9 membranes produced Man5GlcNAc2, demonstrating
that only the Alg12p-dependent elongation occurred and
not addition of an α-1,2-linked mannose. To confirm that
the Man9GlcNAc2 species produced in the assay by wild-
type membranes was identical to the naturally occurring
Man9GlcNAc2, we compared it with a Man9GlcNAc2 ref-
erence oligosaccharide isolated from a ∆alg5 strain. Cells
lacking ALG5 cannot produce Glc-P-Dol and therefore
accumulate Man9GlcNAc2-PP-Dol (te Heesen et al., 1994).
The Man5GlcNAc2 isomer of the digested assay products
co-migrated with the Man5GlcNAc2 isomer obtained after
exo-mannosidase digestion of Man9GlcNAc2 from ∆alg5.
To confirm our results by a genetic approach, we over-
expressed ALG9 in wildtype yeast and analyzed resulting
changes in the LLO profile. Cells were transformed with a
high-copy plasmid containing the ALG9 gene under control
of the endogenous promoter. We then analyzed the pulse-
labeling LLO profile by HPLC (Figure 4) and compared it
with LLO profiles of control cells bearing an empty
plasmid. Three prominent glycan peaks are usually detected
by the HPLC analysis if LLOs of our wildtype cells are
labeled by a [3H]mannose pulse: [3H]Man5GlcNAc2,
[3H]Man8GlcNAc2, and the full-length oligosaccharide
[3H]Glc3Man9GlcNAc2. Accumulation of Man5GlcNAc2-
PP-Dol can be explained by the potentially rate-limiting
translocation step that precedes elongation, by the Alg3p
mannosyltransferase. The full-length precursor likely accu-
mulates because of lack of acceptor peptides or limiting OST
activity. We envisioned that Man8GlcNAc2-PP-Dol accu-
mulates due to limited mannosyltransferase activity for
elongation. In support of this hypothesis, we found that
ALG9 overexpression significantly reduces the relative
abundance of the Man8GlcNAc2 peak compared with the
Man5GlcNAc2 peak (Figure 4). Quantification of seven
independent experiments revealed the Man8GlcNAc2/
Man5GlcNAc2 ratio of 0.71 ± 0.15 in wildtype cells and
0.24 ± 0.06 in ALG9-overexpressing cells. Interestingly, we
did not observe a concomitant increase in the level of the
complete Glc3Man9GlcNAc2 product upon ALG9 overex-
pression. This phenotype has to be expected in a biosyn-
thetic pathway where the flux through the pathway is
controlled by the level of the product. Overexpression of
biosynthetic enzymes in such a system results in an alteration
of relative intermediate concentrations but not in an increase
of the product level. Therefore, we concluded that Alg9p
can add the ninth mannose in vivo as the bottleneck at the
Fig. 2. In vitro assay for elongation of Man7GlcNAc2-PP-Dol. HPLC 
analysis of [3H]mannose-labeled lipid-linked oligosaccharide (LLO) 
substrate from ∆alg12 yeast cells after incubation with membranes isolated 
from different yeast strains. (A) Oligosaccharide standard mix from 
[3H]mannose-labeled yeast LLO. (B) LLO substrate incubated with 
heat-inactivated (5 min/95°C) wildtype membranes. (C) LLO substrate 
incubated with wildtype membranes. (D) LLO substrate incubated with 
∆alg9 membranes. (E) LLO substrate incubated with ∆alg12 membranes. 
Peaks co-migrating with standard oligosaccharides and several 
selected standard oligosaccharides are indicated. M5–M9 refers to 
Man5GlcNAc2–Man9GlcNAc2.
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Man8GlcNAc2 to Man9GlcNAc2 step can be alleviated by
ALG9 overexpression.
Discussion
We provided both biochemical and genetic evidence that
Alg9p is a Dol-P-Man-dependent α-1,2 mannosyltransferase
with dual function: the enzyme transfers the seventh man-
nose residue on the B-arm (i) (Burda et al., 1996) as well as
the ninth mannose residue on the C-arm (k) to the LLO.
We have recently identified a mutation of the human
ALG9 homologue as the cause of a novel type of CDG
(CDG-Il; Frank et al., 2004). Analysis of the LLO from the
patient cells revealed that both ALG9 substrates Man6
GlcNAc2 and Man8GlcNAc2 accumulated, together with
detectable amounts of full-length Glc3Man9GlcNAc2. In
agreement with this observation, expression of human ALG9
cDNAs in yeast mutant strains indicated that the mutated
ALG9 retained residual activity. This shows that the dual
role of ALG9 is conserved also in mammals. ALG9 might
also be bifunctional in amoebae, as Freeze and co-workers
previously isolated a Dictyostelium glycosylation mutant
accumulating Man6GlcNAc2-, Man8GlcNAc2-, and Glc3
Man9GlcNAc2-PP-Dol (HL244, Figure 4 in [Freeze et al.,
1989]). This mutant was not studied further, but on the
basis of our findings most likely the ALG9 locus is affected.
Trypanosomatids lack glucosylated LLOs and transfer
unglycosylated oligosaccharides to protein (Parodi, 1993).
Depending on the species, the mature LLO is Man6Glc
NAc2-PP-Dol, Man7GlcNAc2-PP-Dol, or Man9GlcNAc2-
PP-Dol. Interestingly, no Trypanosoma species has been
identified so far that transfers Man8GlcNAc2 to protein
(Bosch et al., 1988). Our model predicts that cells of the
Man6GlcNAc2-PP-Dol synthesizing species do not have
ALG9 activity, that those producing Man7GlcNAc2-PP-
Dol have ALG9 activity but no ALG12 activity, and that
the Man9GlcNAc2-PP-Dol-producing cells have both
Fig. 3. Exo-α-1,2-mannosidase digest analysis of elongation assay products. HPLC analysis of peaks isolated from a Man7GlcNAc2-PP-Dol elongation 
assay (as in Figure 2) or of Man9GlcNAc2 isolated from a ∆alg5 strain, either mock incubated (–) or digested with α-1,2 specific exo-mannosidase from 
T. reesei (+). (A) Oligosaccharide standard mix of [3H]mannose-labeled lipid-linked oligosaccharide (LLO) from yeast. (B) M7 peak isolated from 
Man7GlcNAc2-PP-Dol input material after hydrolysis. (C) M9 peak isolated from the elongation assay with wildtype membranes (as in Figure 2C). 
(D) M8 peak isolated from the elongation assay with wildtype membranes (as in Figure 2C). (E) M8 peak isolated from the elongation assay with ∆alg9 
membranes (as in Figure 2D). (F) Man9GlcNAc2 peak isolated from LLO of [
3H]mannose-labeled ∆alg5 yeast.
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activities. As the presence of ALG9 is required to form
Man8GlcNAc2-PP-Dol (as without ALG9 biosynthesis
stops at Man6GlcNAc2-PP-Dol), ALG9 will always elon-
gate it further to Man9GlcNAc2-PP-Dol. This explains why
no species with Man8GlcNAc2-PP-Dol as the mature LLO
has been observed.
Removal of mannose i from protein-linked Man9Glc
NAc2 by ER mannosidase I (which yields the Man8Glc
NAc2 isomer B, different from the Man8GlcNAc2 isomer C
formed during LLO biosynthesis [Camirand et al., 1991;
Weng and Spiro, 1996]) has an important function in glyco-
protein folding quality control in the ER (Helenius et al.,
1997; Helenius and Aebi, 2004). This trimming step is
thought to act as a timer for the decision on whether a gly-
coprotein may be exported to distal compartments or if it
has to be degraded via ER-associated degradation (Helenius
et al., 1997; Jakob et al., 1998). It is therefore important
that this Man8GlcNAc2 isomer B only arises from trim-
ming of protein-bound Man9GlcNAc2 and is not formed
during LLO biosynthesis and is transferred to protein. How
is this achieved?
The specificities of the responsible glycosyltransferases
ensure that the sequence of monosaccharide additions is
following a sequential order: after translocation of
Man5GlcNAc2-PP-Dol into the lumen (Helenius et al., 2002),
the B-arm (mannose h and i) is synthesized followed by the
assembly of the C-arm (mannoses j and k). The oligosaccha-
ride is completed with the triglucosyl cap on the A-arm
(glucoses l–n). Interestingly, all the three branches of the mature
Glc3Man9GlcNAc2 oligosaccharide precursor terminate in
α-1,2-linked sugars. This suggests that capping with an α-1,2-
linked monosaccharide signals completion of a branch.
Formation of the Man8GlcNAc2 isomer B during LLO
biosynthesis is prevented by the substrate specificity of the
α-1,6 mannosyltransferase Alg12p that adds mannose j to
LLO (Burda et al., 1999; Cipollo and Trimble, 2002). This
transferase requires an acceptor structure with the complete
B-arm for optimal activity (Burda et al., 1999). Thus, sub-
strates for Alg9p with a Man7GlcNAc2 structure composed
of residues a–h and j are not formed.
Another key factor that ensures that only fully assembled
Glc3Man9GlcNAc2 oligosaccharide is transferred to pro-
tein is the selectivity of the OST for glucosylated LLO
(Murphy and Spiro, 1981; Burda and Aebi, 1998; Spiro,
2000; Karaoglu et al., 2001) in combination with the speci-
ficity of the Alg6p glucosyltransferase. Alg6p is required for
addition of the first glucose (l), the rate-limiting step in LLO
glucosylation (Reiss et al., 1996). Analysis of LLO glucosy-
lation in various alg mutants indicates that Man9GlcNAc2-
PP-Dol is the optimal substrate for Alg6p (Verostek et al.,
1993; Burda et al., 1999; Cipollo and Trimble, 2000). Thus,
capping with α-1,2-linked mannoses by Alg9p serves as a
signal for Alg6p for completion of the LLO.
The relaxed specificity of Alg9p toward the mannose-
acceptor structure rises an interesting question whether
Alg9p can add an α-1,2-linked mannose (at position f) to
the Man3GlcNAc2-PP-Dol observed in ∆alg11 cells
(Cipollo et al., 2001). We have not carried out further stud-
ies on the substrate specificity so far. However, some con-
clusions on limitations of the substrate spectrum can be
drawn from previously reported analyses of mutants
affected in GPI-anchor biosynthesis. Besides Alg9p, two
other members of the Man-P-Dol-dependent α-1,2 manno-
syltransferase family, Smp3p (Grimme et al., 2001) and
Gpi10p (Canivenc-Gansel et al., 1998; Sutterlin et al.,
1998), are known in yeast. Both are involved in GPI-anchor
biosynthesis, act on a lumenally oriented substrate, and
might have evolved from a common ancestor with Alg9p
(Oriol et al., 2002). Overall sequence similarity to Alg9p is
low (Gpi10p 20% identical, 36% similar over 616 amino
acids; Smp3p 19% identical, 36% similar over 555 amino
acids), but they share a similar topology as judged from the
hydrophobicity profiles (Kyte-Doolittle hydropathy algo-
rithm). The gpi10-1 mutant is affected in addition of the third
mannose to GPI-anchor precursors but has a normal LLO
profile (Canivenc-Gansel et al., 1998). As demonstrated by
the inviability of SMP3- or GPI10-deletion mutants
(Sutterlin et al., 1998), they are not redundant to each
other. Assuming SMP3 and GPI10 do not have additional
unknown functions indicates that the relaxed LLO sub-
strate specificity of Alg9p does not extend to GPI-anchor
intermediates, as it could otherwise compensate for loss of
SMP3 or GPI10.
Materials and methods
Yeast strains and media
Standard yeast media and genetic techniques were used
(Guthrie and Fink, 1991). Yeast strains used in this study
are listed in Table I.
Fig. 4. Effect of ALG9 overexpression on the lipid-linked oligosaccharide 
(LLO) profile of wildtype cells. HPLC analysis of LLO from [3H]mannose-
labeled yeast cells transformed with (A) YEp352, empty multicopy 
plasmid and (B) pALG9, multicopy plasmid carrying ALG9. Selected 
oligosaccharide species are indicated as M5 (Man5GlcNAc2), M8 
(Man8GlcNAc2), and G3M9 (Glc3Man9GlcNAc2).
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Plasmids
pALG9 (Jakob et al., 1998) is a derivative of YEp352 (Hill
et al., 1986) and contains a 2.5 kbp BglII-KpnI fragment of
yeast genomic DNA encompassing the ALG9 ORF plus
0.5 kbp upstream sequence in the BamHI-KpnI sites.
HPLC analysis of [3H]-labeled oligosaccharides
HPLC analysis was carried out as described (Zufferey et al.,
1995).
Isolation of [3H]Man7GlcNAc2-PP-Dol substrate
∆alg12 yeast were grown in YPD medium at 30°C to late log
phase and 80 OD546 cells pulse labeled for 12 min with 125
µCi [3H]mannose (20 Ci/mmol; ICN Pharmaceuticals, Costa
Meso, CA) as described previously (Zufferey et al., 1995).
Workup of LLO was stopped after the CHCl3 : CH3OH : H2O
(10:10:3) (v/v/v) extraction, and the glycolipids were stored
at –20°C until use.
[3H]mannose labeling of ALG9-overexpressing cells
Wildtype yeast (SS328) transformed with either pALG9 or
YEp352 were grown in 50 mL YPD at 30°C to mid-log
phase (OD546 1.0 ± 0.1) and pulse labeled for 12 min with
25 µCi [3H]mannose as described previously (Zufferey et al.,
1995). Half of the isolated hydrolyzed oligosaccharides were
analyzed by HPLC (see Results).
For the assessment of the overexpression effect, individ-
ual peak areas were quantified with the FLO-One software
(Packard Biosciences, Meridan, CT), and the ratios of the
Man8GlcNAc2 and Man5GlcNAc2 peaks (M8/M5) were
calculated for each trace.
Preparation of membranes
Yeast strains were grown to mid-log phase in YPD medium
at 30°C.
200 OD546 cells were harvested and washed once in
washing buffer (50 mM HEPES/NaOH pH 7.5, 3 mM
MgCl2). The cells were resuspended in cold lysis buffer
(washing buffer supplemented with 1 mM DTT and pro-
tease inhibitors: 1 mM PMSF, 2 µg/mL Leupeptin, and
1 µg/mL E-64) and lysed by vortexing for 10 min with glass
beads. The liquid was collected by puncturing the tubes
with a hot needle and centrifugation at 1000 × g for 1 min.
Intact cells, cell debris, and nuclei were removed by centrif-
ugation for 5 min at 1000 × g. This supernatant was then
centrifuged for 45 min at 50,000 × g to obtain the membrane
pellet. The pellet was resuspended and homogenized in
storage buffer (lysis buffer supplemented with 35% [v/v]
glycerol). Membranes were shockfreezed in liquid nitrogen
and stored at –80°C until use. Protein concentration was
determined using the bicinchoninic acid method.
In vitro assay for elongation of [3H]Man7GlcNAc2-PP-Dol
Membranes (340 µg protein) were incubated with 1 mM GDP-
Man and 1 mM CTP in 44 mM HEPES/NaOH pH 7.5, 3 mM
MgCl2, 1 mM DTT, 30% (v/v) glycerol in a volume of 20 µL.
After incubation for 10 min at 25°C, 100 µL of
[3H]Man7GlcNAc2-PP-Dol substrate (60,000–80,000 cpm)
in 50 mM HEPES/NaOH pH 6.5, 60 mM NaCl, 5.8 mM
MgCl2, 4.8 mM CaCl2, 4.8 mM MnCl2, 1 mM DTT, 0.3% (w/v)
NP40 was added. The reaction was stopped after incuba-
tion at 25°C after 20 min by addition of 800 µL CHCl3 :
MeOH (1:1) (v/v) and thorough vortexing. The supernatant
after centrifugation for 5 min at 9,000 x g/4°C was saved,
and the pellet was re-extracted with 800 µL CHCl3 : MeOH
: H2O (10:10:3) (v/v/v). Both supernatants were combined,
dried under nitrogen, and subjected to mild acid hydrolysis
and analyzed by HPLC as described previously (Zufferey
et al., 1995).
Oligosaccharide digestion with exo-α-1,2 mannosidase
Single peaks from HPLC analysis of assay products or
in vivo labeling were collected, dried, and resuspended in incu-
bation buffer (100 mM HOAc/NaOAc pH 5.0). The samples
were split and incubated with or without 10 µU Trichoderma
reesei exo-α-1,2 mannosidase (a gift from R. Contreras,
Ghent) for 96 h at 37°C in a volume of 30 µL. After heat inac-
tivation of the enzyme for 5 min at 95°C, the samples were
spin-filtered and analyzed by HPLC as described above. Initial
experiments were performed with an exo-α-1,2 mannosidase
from Aspergillus saitoi (a gift from Dr. T. Butters, Oxford).
Protein sequence alignments
The protein sequences used have the accession numbers
NP_014180 (Alg9p), NP_011373 (Gpi10p), NP_014792
(Smp3p), and NP_014350 (Alg11p). Sequences were
aligned using the Clustal W algorithm with a BLOSUM
scoring matrix.
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Table I. Yeast strains used in this study
Strain Genotype Source
SS328 MATα ade2-101 his3∆200 
lys2-801 ura3-52
Vijayraghavan 
et al. (1989)
YG414 MATα ade2-101 ura3-52 
his3∆200 lys2-801 ∆alg9::kanMX
Burda et al. (1996)
YG840 MATα ade2-101 ura3-52 
his3∆200 lys2–801 ∆alg12::kanMX4
Burda et al. (1999)
C.G. Frank and M. Aebi 
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